Insider trading

Period: 120 months Stock: ALEC + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

180 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

180 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

180 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

180 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
180 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
180 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

180 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Jul 2021
Sold, plan not stated
$310.81K 9,981 at 31.14
100%
Sold half or more
1 Jul 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$594.12K 26,726 at 22.23
9.8%
16 Jun 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$102.05K 4,600 at 22.18
1.7%
15 Jun 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$661.95K 30,000 at 22.07
9.9%
8 Jun 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 3×
$367.75K 19,175 at 19.18
6.5%
2 Jun 2021
Yu Calvin Vice President, Finance
Sold, plan not stated
$32.77K 1,844 at 17.77
1.4%
21 May 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$271.68K 14,975 at 18.14
5.2%
18 May 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$75.79K 4,200 at 18.04
1.5%
7 Apr 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 2×
$428.05K 22,300 at 19.20
9.4%
23 Mar 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$306.50K 13,800 at 22.21
6.1%
22 Mar 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 2×
$689.38K 30,000 at 22.98
12.3%
9 Mar 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$347.40K 19,175 at 18.12
8.2%
9 Feb 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$399.05K 19,175 at 20.81
8.2%
26 Jan 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$491.54K 27,308 at 18.00
11.3%
25 Jan 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$540.23K 30,000 at 18.01
12.3%
20 Jan 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$154.21K 8,567 at 18.00
3.9%
19 Jan 2021
Paul Robert Chief Medical Officer
Sold, plan not stated
$543.55K 30,000 at 18.12
12.3%
15 Jul 2020
Paul Robert Chief Medical Officer
Sold, plan not stated 2×
$229.64K 10,000 at 22.96
4.5%
23 Jun 2020
MCGUIRE TERRANCE Director · indirect
Sold, plan not stated
$138.06K 4,377 at 31.54
0.0%
23 Jun 2020
Sold, plan not stated
$138.06K 4,377 at 31.54
0.0%
15 Jun 2020
Paul Robert Chief Medical Officer
Sold, plan not stated 2×
$296.14K 10,000 at 29.61
4.3%
3 Jun 2020
Yu Calvin Vice President, Finance
Sold, plan not stated 2×
$41.98K 1,343 at 31.26
1.2%
15 May 2020
King Robert Chief Development Officer
Sold, plan not stated 3×
$404.96K 15,000 at 27.00
3.0%
15 May 2020
Paul Robert Chief Medical Officer
Sold, plan not stated 3×
$270.03K 10,000 at 27.00
4.1%
16 Apr 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$1.46M 62,183 at 23.53
3.2%
15 Apr 2020
Paul Robert Chief Medical Officer
Sold, plan not stated
$222.70K 10,000 at 22.27
3.9%
14 Apr 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$546.39K 23,231 at 23.52
1.2%
9 Apr 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$6.85M 288,101 at 23.79
13.0%
8 Apr 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$1.95M 82,614 at 23.65
4.0%
7 Apr 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$211.83K 9,170 at 23.10
0.5%
31 Mar 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$6.13M 250,000 at 24.50
11.0%
25 Mar 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$1.39M 56,411 at 24.66
2.6%
24 Mar 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$1.65M 67,644 at 24.45
3.1%
23 Mar 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$380.28K 14,598 at 26.05
0.7%
13 Mar 2020
Paul Robert Chief Medical Officer
Sold, plan not stated 4×
$229.29K 10,000 at 22.93
3.8%
2 Mar 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$48.73M 1,874,203 at 26.00
100%
Sold half or more
14 Feb 2020
King Robert Chief Development Officer
Sold, plan not stated 2×
$443.38K 15,000 at 29.56
3.0%
14 Feb 2020
Paul Robert Chief Medical Officer
Sold, plan not stated 2×
$295.39K 10,000 at 29.54
3.7%
7 Feb 2020
Yu Calvin Vice President, Finance
Sold, plan not stated
$841.64K 24,033 at 35.02
17.8%
7 Feb 2020
Oney Sabah Chief Business Officer
Sold, plan not stated
$697.10K 19,900 at 35.03
3.4%
6 Feb 2020
Yu Calvin Vice President, Finance
Sold, plan not stated
$91.74K 2,621 at 35.00
2.1%
6 Feb 2020
Oney Sabah Chief Business Officer
Sold, plan not stated
$3.50K 100 at 35.00
0.0%
5 Feb 2020
Paul Robert Chief Medical Officer
Sold, plan not stated
$321.00K 10,000 at 32.10
3.5%
4 Feb 2020
Yu Calvin Vice President, Finance
Sold, plan not stated
$1.91M 63,541 at 30.04
33.6%
4 Feb 2020
Oney Sabah Chief Business Officer
Sold, plan not stated
$500.01K 16,667 at 30.00
2.7%
4 Feb 2020
Sold, plan not stated
$296.70K 10,000 at 29.67
50.0%
Sold half or more
3 Feb 2020
Wehner David M. Director
Bought
$500.00K 20,000 at 25.00
81.2%
First buy on file
30 Jan 2020
Paul Robert Chief Medical Officer
Sold, plan not stated
$224.00K 8,000 at 28.00
2.8%
27 Jan 2020
Oney Sabah Chief Business Officer
Sold, plan not stated
$362.40K 14,467 at 25.05
2.4%
23 Jan 2020
Paul Robert Chief Medical Officer
Sold, plan not stated 2×
$145.92K 6,000 at 24.32
2.1%
Showing 101–150 of 180. ← Newer Page 3 of 4 Older →